Cellid, Co., Ltd.

299660.KQ·KOSDAQ·Healthcare
Compare
1,790.00−27.00 (−1.49%)today
At close: Nov 5, 3:30 PM KST · May be delayed up to 20 min · KRW

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,817.00
Open1,962.00
Day range1,777.001,962.00
52-week range973.004,760.00
Off day high−8.77%
Off 52-week high−62.39%
Volume135.18K
Avg. volume (3M)1.46M
Market cap54.78B
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding30.61M
Short interest—
Earnings date—
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
299660.KQ BNTX 261780.KQ 688520.SS IBRX 6547.TWO
Market cap 54.78B 22.49B 103.62B 15.35B 9.46B 15.63B
P/E (TTM) — — — — — —
Forward P/E — -16.6 — 21.9 -121.8 32.6
Price/book — 1.1 — -22.6 -9.0 4.4
Dividend yield — — — — — —
1-year change −46.79% −12.24% +44.97% −37.00% +321.23% +42.31%
Today −1.49% +4.35% −2.90% +1.02% +7.72% −2.16%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

EE Times Asia··3 outlets

Cellid Joins Qualcomm Program to Develop Snapdragon-based AR Glasses

Home » AR/VR » Cellid Joins Qualcomm Program to Develop Snapdragon-based AR Glasses Cellid will use Qualcomm's development platform to build reference designs and shorten AR glasses development cycles. Japan-based Cellid Inc. has joined…

More from 2 other outlets

From the 4Search news index, newest first.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance